neuromyotonia
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
- neuromyotonia (Isaacs syndrome) is a disorder of peripheral nerve hyperexcitability
characterized by myokymia, muscle cramps and stiffness, delayed muscle relaxation
after contraction (pseudomyotonia), and hyperhidrosis, associated with well described
spontaneous electromyographic features
- usually neuromyotonia is an acquired disorder associated with autoantibodies against neuronal voltage-gated potassium channels
- familial neuromyotonia occurs very rarely
- mutations of KCNA1, encoding the K+ channel subunit hKv1.1, have been reported in rare families with neuromyotonia
- clinical features are diverse and include
cramps, generalized muscle twitching, stiffness, and pseudomyotonia
- some patients experience paresthesias or hyperhidrosis that may be secondary to muscle overactivity
- underlying electrophysiologic basis of Isaacs’
syndrome is the spontaneous repetitive burst of single motor-unit potentials,
with high intraburst frequency
- most common electromyographic abnormalities
are myokymic and neuromyotonic discharges
- both terms are used to describe
this spontaneous electrical activity, and both forms of discharge are sometimes
seen in the same patient
- main difference between them arises from the higher frequencies (150-300 Hz) and waning features of neuromyotonic discharges
- both terms are used to describe
this spontaneous electrical activity, and both forms of discharge are sometimes
seen in the same patient
- most common electromyographic abnormalities
are myokymic and neuromyotonic discharges
-
distinction between neuromyotonia and other entities, such as cramp-fasciculation
syndrome and stiff-man syndrome, lies in the electromyographic and clinical findings
- rippling-muscle disease is a rare autosomal-dominant disorder (characterized by mechanically induced, involuntary muscle contractions) which should always be included in the differential diagnosis of Isaacs’ syndrome
- in addition to conventional pharmacotherapy with anticonvulsants such as phenytoin or carbamazepine, immunomodulatory treatments using high doses of intravenous immunoglobulin and plasmapheresis have also been employed (3)
Reference:
- (1) Falace A et al. Inherited neuromyotonia: A clinical and genetic study of a family Neuromuscular Disorders 2007; 17: 23-27
- (2) Am J Med Sci. 2000 Apr;319(4):209-16.
- (3) Gonzalez G et al. Acquired neuromyotonia in childhood: case report and review.Pediatr Neurol. 2008 Jan;38(1):61-3
Last reviewed 01/2018
Links: